12:00 AM
 | 
Jan 23, 2012
 |  BC Week In Review  |  Company News  |  Deals

Vernalis, Servier deal

The partners will use Vernalis' fragment and structure-based drug discovery technology to identify therapeutics against...

Read the full 53 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >